New global guidelines warn against obesity drugs for children under 10

Children under 10 should not be given obesity drugs or GLP-1 weight-loss injections such as Mounjaro and Wegovy, new global guidelines , external from the World Health Organization say.

Most of these medications are only licensed for children or adolescents older than this, but some doctors prescribe them off-label, and drug companies are testing them in children as young as six.

WHO says the care should focus on healthy eating and exercise, not medicine or surgery, although they do not oppose drug trials.